Target Price | €222.64 |
Price | €190.40 |
Potential |
16.93%
register free of charge
|
Number of Estimates | 14 |
14 Analysts have issued a price target Sartorius Stedim Biotech 2025 .
The average Sartorius Stedim Biotech target price is €222.64.
This is
16.93%
register free of charge
€310.00
62.82%
register free of charge
€134.00
29.62%
register free of charge
|
|
A rating was issued by 14 analysts: 9 Analysts recommend Sartorius Stedim Biotech to buy, 4 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Sartorius Stedim Biotech stock has an average upside potential 2025 of
16.93%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion € | 2.78 | 2.76 |
20.53% | 0.44% | |
EBITDA Margin | 26.02% | 27.54% |
29.17% | 5.85% | |
Net Margin | 11.78% | 8.51% |
55.54% | 27.77% |
13 Analysts have issued a sales forecast Sartorius Stedim Biotech 2024 . The average Sartorius Stedim Biotech sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Sartorius Stedim Biotech EBITDA forecast 2024. The average Sartorius Stedim Biotech EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
12 Sartorius Stedim Biotech Analysts have issued a net profit forecast 2024. The average Sartorius Stedim Biotech net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share € | 3.36 | 2.42 |
64.67% | 27.98% | |
P/E | 79.42 | |
EV/Sales | 7.62 |
12 Analysts have issued a Sartorius Stedim Biotech forecast for earnings per share. The average Sartorius Stedim Biotech <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Sartorius Stedim Biotech stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Sartorius Stedim Biotech...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.